BALYASNY ASSET MANAGEMENT L.P. - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 179 filers reported holding TG THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,223,427
-93.1%
146,343
-79.6%
0.00%
-94.9%
Q2 2023$17,809,386
+233.3%
716,964
+101.8%
0.04%
+200.0%
Q1 2023$5,342,930
+8517.6%
355,248
+3283.6%
0.01%
Q3 2022$62,000
-98.9%
10,499
-98.2%
0.00%
-100.0%
Q1 2022$5,531,000
+9.4%
581,587
+118.5%
0.02%0.0%
Q4 2021$5,057,000
+1898.8%
266,176
+935.4%
0.02%
+466.7%
Q1 2020$253,000
-55.9%
25,707
-74.9%
0.00%0.0%
Q3 2018$574,000
-16.2%
102,571
+97.0%
0.00%0.0%
Q2 2018$685,00052,0600.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
RA Capital Management 2,813,779$33,568,0003.32%
Opaleye Management Inc. 300,000$3,579,0001.50%
BRIDGER MANAGEMENT, LLC 3,068,315$36,605,0001.21%
SECTORAL ASSET MANAGEMENT INC 1,521,667$18,153,0000.77%
STONERIDGE INVESTMENT PARTNERS LLC 332,576$3,968,0000.53%
Eventide Asset Management 537,600$6,414,0000.32%
Baker Brothers Advisors 2,003,991$23,908,0000.20%
Quantitative Systematic Strategies LLC 25,270$302,0000.08%
Candriam S.C.A. 236,200$2,818,0000.08%
COLUMBUS CIRCLE INVESTORS 705,389$8,415,0000.07%
View complete list of TG THERAPEUTICS INC shareholders